Trial at a glance
Trial Dates03/2025 – 04/2026
ConditionADHD, Anxiety, Generalized Anxiety, Social Anxiety Disorder
Trial DrugPlacebo, Centanafadine
Enrollment315
Trial StatusCompleted
Trial results
Plain Language Results coming April 29, 2027
Trial ID: 405-201-00180
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
CT.gov ID:
Summary
Primary: To evaluate the efficacy of CTN in adults ages with ADHD and comorbid anxiety (AISRS) Key Secondary: To assess the efficacy of CTN in adults ages with ADHD and comorbid anxiety